Shanghai Chuangli Group (603012.SH) is planning to raise up to 200 million yuan through a private placement to the controlling shareholder for the purpose of supplementing working capital.
Chuangli Group (603012.SH) disclosed the plan to issue A shares to specific investors. The target investors for the stock issuance are Quanyi...
Shanghai Chuangli Group (603012.SH) disclosed a plan to issue A-shares to specific entities. The entity purchasing the shares is Quanye (Hangzhou) Technology Co., Ltd., which will subscribe in cash. Quanye (Hangzhou) Technology Co., Ltd. is an enterprise controlled by Mr. Shi Liangxi, the actual controller of the company, making this issuance to specific entities a related party transaction. The number of shares to be issued shall not exceed 49.7512 million shares, at a price of 4.02 yuan per share, with a total fundraising amount of no more than 200 million yuan (including this amount). The net proceeds from the fundraising, after deducting relevant issuance expenses, will be used entirely to supplement working capital.
Related Articles

Zhuzhou CRRC Times Electric (03898): Niu Jie resigns as Deputy General Manager.

STANCHART(02888) spent 10.0537 million pounds on January 2 to repurchase 544,200 shares.

Humanwell Healthcare (600079.SH): HW221043 tablets have obtained the drug clinical trial approval notification.
Zhuzhou CRRC Times Electric (03898): Niu Jie resigns as Deputy General Manager.

STANCHART(02888) spent 10.0537 million pounds on January 2 to repurchase 544,200 shares.

Humanwell Healthcare (600079.SH): HW221043 tablets have obtained the drug clinical trial approval notification.

RECOMMEND

Hong Kong Listed Companies’ Return To A Shares Heats Up As New “H To Shenzhen A” Case Emerges
05/01/2026

What Do The Top Ten Biopharma IPOs Of 2025 Tell Us?
05/01/2026

Asia’s Stock Markets Deliver A Strong 2025: Korea Soars 76%, Japan Tops Bubble‑Era Peak, Indonesia Records Best Year In 11 Years
05/01/2026


